7.13
-0.91 (-11.32%)
-0.91 (-11.32%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 659,579 |
|
|||||
| News | - | ||||||
| Day High | 8.1352 | Low High |
|||||
| Day Low | 6.92 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptevo Therapeutics Inc | APVO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.91 | -11.32% | 7.13 | 00:00:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.01 | 6.92 | 8.1352 | 7.03 | 8.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,303 | 659,579 | $ 7.55 | $ 4,979,682 | - | 6.38 - 47.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:56:40 | 16 | $ 7.13 | USD |
Period:
Draw Mode:
Aptevo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 34.92M | 4.90M | 2.88M | $ 4.31M | $ - | -5.23 | -1.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 45.40% |
Aptevo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.81 | 14.10 | 6.92 | 11.09 | 3,698,155 | -5.68 | -44.34% |
| 1 Month | 15.80 | 22.0799 | 6.38 | 15.79 | 11,029,174 | -8.67 | -54.87% |
| 3 Months | 17.12 | 22.0799 | 6.38 | 15.79 | 3,583,888 | -9.99 | -58.35% |
| 6 Months | 26.00 | 31.76 | 6.38 | 15.94 | 1,691,239 | -18.87 | -72.58% |
| 1 Year | 47.53 | 47.98 | 6.38 | 16.52 | 885,320 | -40.40 | -85.0% |
| 3 Years | 2.34 | 60.00 | 0.195 | 11.42 | 742,973 | 4.79 | 204.7% |
| 5 Years | 1.92 | 60.00 | 0.195 | 9.92 | 544,806 | 5.21 | 271.35% |
Aptevo Therapeutics Description
| Aptevo Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. The company develops its drug candidates using its ADAPTIR platform. The products under its pipeline are APVO436, which targets CD123 and CD3 and redirects T-cell cytotoxicity to the tumor; ALG.APV-527, for the treatment of a broad spectrum of cancers over-expressing the 5T4 tumor antigen, including mesothelioma, non-small-cell-lung, head & neck, pancreatic, renal, ovarian, and bladder cancers; and APVO603. |
